Cancer fusion genes targeted with CRISPR
Aggressive human prostate and liver tumours have been shrunk in mice by targeting a ‘fused’ gene mutation using CRISPR/Cas9...
Cancer that develops in the prostate (a gland that forms part of the male reproductive system).
Aggressive human prostate and liver tumours have been shrunk in mice by targeting a ‘fused’ gene mutation using CRISPR/Cas9...
A new study has found that up to 66 percent of cancer-causing mutations can be attributed to random mistakes made during DNA replication...
A new study has found over 280 genes associated with male-pattern baldness...
Canadian scientists have identified a genetic fingerprint that indicates which prostate cancer tumours may develop into a more aggressive form of the disease after treatment...
Genetic mutations on several genes including BRCA2 have been associated with prostate cancer; while in a separate study, a BRCA1 mutation has been linked to a particular form of uterine cancer...
A treatment for prostate cancer, combining radiotherapy and a new type of gene therapy, is both safe and effective, a study has found...
Researchers have identified the genetic mutations that drive resistance to the hormone therapy abiraterone in patients with advanced prostate cancer...
Researchers have estimated that around 65 percent of variation in cancer rates between tissue types is related to the number of stem cell divisions, explaining why cancer occurs more commonly in some parts of the body than others...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.